Response to media inquiries on The New York Times article (3/20/14) regarding PETA allegations:
LEXINGTON, Ky. (March 20, 2014) — Breeders’ Cup Limited today released the following statement from President and Chief Executive Officer Craig Fravel:
“While the individuals involved are entitled to due process after a fair and impartial investigation, much of the alleged behavior depicted in today's news accounts is unacceptable, deeply troubling and, we believe, not a reflection of the way we strive as an industry to properly care for our horses. The vast majority of participants in Thoroughbred racing work hard to care for the animals entrusted to them in an ethical and responsible manner and to comply with veterinary best practices and regulatory standards.
“We believe that it is imperative that Thoroughbred racing in the United States aggressively pursue adoption of the uniform medication rules that contain important reforms relating to the administration of therapeutic medications and that the multiple violation penalties associated with these model rules should be implemented as quickly as possible. Moreover, the administration of medication to horses should be done in the context of an established veterinarian/patient relationship subject to guidelines requiring individual diagnosis and treatment plans. Finally, we strongly believe that workers in our industry should be treated fairly and with respect and that employers in our industry should comply with applicable laws governing the workplace.
“At its annual World Championships, Breeders’ Cup has worked to set best-in-class standards for safety, security, race-readiness and testing. Breeders’ Cup will continue to support medication and other reform efforts to ensure that a culture of respect and care for the animals is the norm and that those who do not comport with regulatory and ethical standards do not find comfort or shelter in our business. They put at risk the good work and reputations of many other industry participants.”